SCHEMBL13513879

SCHEMBL13513879

CC1CNCCN1S(=O)(=O)c1cccc2c(O)nccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCD Q05655 7/20 0.65
▸ PRKACA P17612 5/20 0.65
▸ PRKD3 O94806 5/20 0.65
▸ PRKCZ Q05513 5/20 0.65
▸ PRKCE Q02156 5/20 0.65
▸ PRKD1 Q15139 5/20 0.65
▸ PRKACG P22612 4/20 0.65
▸ PRKACB P22694 4/20 0.65
▸ PRKCG P05129 4/20 0.65
▸ PRKCB P05771 4/20 0.65
▸ PRKCA P17252 4/20 0.65
▸ PRKCH P24723 4/20 0.65
▸ PRKCI P41743 4/20 0.65
▸ PRKCQ Q04759 4/20 0.65
▸ CYP3A4 P08684 4/20 0.65
▸ NFKB1 P19838 3/20 0.65
▸ SMN1; SMN2 Q16637 2/20 0.65
▸ TSHR P16473 2/20 0.65
▸ ALOX15 P16050 2/20 0.65
▸ CYP2C19 P33261 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30439363 0.94 PRKCD (0.57) PRKCDPRKACAPRKD3PRKCZPRKCE
SCHEMBL23795402 0.94 PRKCD (0.57) PRKCDPRKACAPRKD3PRKCZPRKCE
SCHEMBL30439459 0.94 PRKCD (0.57) PRKCDPRKACAPRKD3PRKCZPRKCE
SCHEMBL23795296 0.94 PRKCD (0.57) PRKCDPRKACAPRKD3PRKCZPRKCE
Hydrochloric Acid SCHEMBL23795335 0.93 PRKCD (0.58) PRKCDPRKACAPRKD3PRKCZPRKCE
Hydrochloric Acid SCHEMBL23795390 0.93 PRKCD (0.58) PRKCDPRKACAPRKD3PRKCZPRKCE
Hydrochloric Acid SCHEMBL30439323 0.93 PRKCD (0.58) PRKCDPRKACAPRKD3PRKCZPRKCE
Hydrochloric Acid SCHEMBL30438942 0.93 PRKCD (0.58) PRKCDPRKACAPRKD3PRKCZPRKCE
SCHEMBL12306063 0.89 PRKCD (0.67) PRKCDPRKACAPRKD3PRKCZPRKCE
SCHEMBL12306789 0.87 PRKCD (0.65) PRKCDPRKACAPRKD3PRKCZPRKCE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110294789-A1 COMPOUNDS FOR RHO KINASE INHIBITION AND FOR IMPROVING LEARNING AND MEMORY AMNESTIX, INC. 2011-12-01 — — US disclosed
WO-2009151845-A9 COMPOUNDS FOR RHO KINASE INHIBITION AND FOR IMPROVING LEARNING AND MEMORY AMNESTIX, INC. (US) 2010-01-28 — — WO disclosed
WO-2009151845-A1 COMPOUNDS FOR RHO KINASE INHIBITION AND FOR IMPROVING LEARNING AND MEMORY AMNESTIX, INC. (US) 2009-12-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294789-A1 COMPOUNDS FOR RHO KINASE INHIBITION AND FOR IMPROVING LEARNING AND MEMORY ROCK1, IRAK1, ROCK2 PRKCD 379/4885PRKACA 689/4885PRKD3 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback